CLX-106

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameCLX-106
Drug Alias NameCLX-106CIX-601
ClassificationSmall molecules
Mechanisms of ActionHeme oxygenase 1 modulators
TargetsHeme oxygenase 1
Therapy Area/IndicationsPsoriasisMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIndia
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCellix Bio Pvt Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsPsoriasisMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A